Myocarditis Associated With Immune Checkpoint Inhibitors in Patients With Thymoma
- PMID: 38939434
- PMCID: PMC11198541
- DOI: 10.1016/j.jacadv.2023.100428
Myocarditis Associated With Immune Checkpoint Inhibitors in Patients With Thymoma
References
-
- Priemer D.S., Davidson D.D., Loehrer P.J., Badve S.S. Giant cell polymyositis and myocarditis in a patient with thymoma and myasthenia gravis: a postviral autoimmune process? J Neuropathol Exp Neurol. 2018;77:661–664. - PubMed
-
- Muller M., Cooper L.T., Heidecker B. Diagnosis, risk stratification and management of myocarditis. Heart. 2022;108:1486–1497. - PubMed
-
- Cho J., Kim H.S., Ku B.M., et al. Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: an open-label phase II trial. J Clin Oncol. 2019;37:2162–2170. - PubMed
LinkOut - more resources
Full Text Sources